Xueqiang Peng
- Cancer Research top 2%
- MicroRNA in disease regulation 10
- Cancer-related molecular mechanisms research 9
- Molecular Biology top 5%
- Extracellular vesicles in disease 14
- RNA modifications and cancer 7
- RNA Interference and Gene Delivery 4
- Epigenetics and DNA Methylation 3
- Immunology top 10%
- Immunotherapy and Immune Responses 4
- Epidemiology top 10%
- Autophagy in Disease and Therapy 12
- Biochemistry top 10%
In The Last Decade
Xueqiang Peng
39 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 107
- Cancer Research 1.1k
- Molecular Biology 1.5k
- Immunology 320
- Epidemiology 381
- Biochemistry 71
Countries citing papers authored by Xueqiang Peng
This map shows the geographic impact of Xueqiang Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xueqiang Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xueqiang Peng more than expected).
Fields of papers citing papers by Xueqiang Peng
This network shows the impact of papers produced by Xueqiang Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xueqiang Peng. The network helps show where Xueqiang Peng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xueqiang Peng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 38 | |
| 2 | 2024 | 15 | |
| 3 | 2024 | 12 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 3 | |
| 6 | 2024 | 15 | |
| 7 | 2023 | 79 | |
| 8 | 2023 | 19 | |
| 9 | 2023 | 69 | |
| 10 | 2023 | 26 | |
| 11 | Exosomes in the hypoxic TME: from release, uptake and biofunctions to clinical applicationsbreakdown → | 2022 | 144 |
| 12 | 2022 | 13 | |
| 13 | 2022 | 46 | |
| 14 | 2022 | 14 | |
| 15 | 2022 | 56 | |
| 16 | 2020 | 36 | |
| 17 | 2019 | 152 | |
| 18 | 2019 | 68 | |
| 19 | 2019 | 41 | |
| 20 | 2017 | 174 |
About Xueqiang Peng
Xueqiang Peng is a scholar working on Cancer Research, Molecular Biology and Biological Psychiatry, having authored 39 papers that have together received 2.1k indexed citations. Recurring topics across this work include Extracellular vesicles in disease (14 papers), Autophagy in Disease and Therapy (12 papers), MicroRNA in disease regulation (10 papers), Cancer-related molecular mechanisms research (9 papers), RNA modifications and cancer (7 papers), RNA Interference and Gene Delivery (4 papers), Immunotherapy and Immune Responses (4 papers) and Epigenetics and DNA Methylation (3 papers). The work is most often cited by research in Cancer Research (1.1k citations), Molecular Biology (1.5k citations) and Immunology (320 citations). Xueqiang Peng has collaborated with scholars based in China, Sweden and Singapore. Frequent co-authors include Hangyu Li, Liang Yang, Shibo Wei, Jingang Liu, Qing Fan, Shuo Yang, Yingbo Ma, Hongyuan Jin, Mingyao Huang and Jiaxing Liu. Their work appears in journals such as Journal of Clinical Investigation, Gene and Molecular Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.